Geron Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Geron Stock Summary

Geron competes with Viking Therapeutics, TG Therapeutics, X4 Pharmaceuticals, PDS Biotechnology, and Madrigal Pharmaceuticals. Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. The company was incorporated in 1990 and is headquartered in Foster City, California. Geron Corp operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 69 people.

Geron Key Financial Ratios

Geron Key Balance Sheet Accounts

Geron Key Income Statement Accounts

Geron Key Cash Accounts

Geron Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Geron's current stock value. Our valuation model uses many indicators to compare Geron value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Geron competition to find correlations between indicators driving Geron's intrinsic value. More Info.Geron is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Geron's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Geron's earnings, one of the primary drivers of an investment's value.

Geron Systematic Risk

Today, most investors in Geron Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Geron's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Geron growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Geron help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Geron. We use our internally-developed statistical techniques to arrive at the intrinsic value of Geron based on widely used predictive technical indicators. In general, we focus on analyzing Geron Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Geron's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Geron. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.